Abdullah A. Elgazar

793 citations

30 papers · 583 indexed · h-index 16

Organic Chemistry top 5%
Molecular Biology
Pharmacology
Computational Theory and Mathematics top 10%
Pharmacology top 10%

Co-authors: Abdelrahman Hamdi Farid A. Badria Wagdy M. Eldehna Mohammed A. El‐Magd Samar S. Tawfik Hala M. El-Hefnawy Nabil Mohie Abdel‐Hamid Ramadan A. El-Domany
Topics: Synthesis and biological activity (7 papers)Computational Drug Discovery Methods (7 papers)Click Chemistry and Applications (6 papers)
Cited by: Organic Chemistry Pharmacology Computational Theory and Mathematics
Journals: SHILAP Revista de lepidopterologíaChemistry - A European Journal Molecules
Partner nations: Egypt Saudi Arabia United Kingdom

In The Last Decade

Abdullah A. Elgazar

26 papers receiving 576 citations

Peers

Countries citing papers authored by Abdullah A. Elgazar

Since Specialization

Citations

This map shows the geographic impact of Abdullah A. Elgazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah A. Elgazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah A. Elgazar more than expected).

Fields of papers citing papers by Abdullah A. Elgazar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullah A. Elgazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah A. Elgazar. The network helps show where Abdullah A. Elgazar may publish in the future.

Co-authorship network of co-authors of Abdullah A. Elgazar

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullah A. Elgazar. A scholar is included among the top collaborators of Abdullah A. Elgazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullah A. Elgazar. Abdullah A. Elgazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Khellin Mitigates Cisplatin-Induced Renal Injury by Targeting Oxidative Stress, Inflammation, and Apoptosis: Integration of Network Pharmacology, Molecular Docking, and Preclinical Validation 2025 ·Pharmaceuticals ·(unknown),(unknown),(unknown),(unknown),Foad Farrag,Abdelrahman Hamdi,Mohammed A. El‐Magd,Abdullah A. Elgazar	0
2	New phenylpiperazine-thiazolidine-2,4-dione hybrids targeting MAO inhibition: Synthesis, biological evaluation, kinetic study and in silico insights 2025 ·Bioorganic & Medicinal Chemistry ·(unknown),Mohammad M. Al‐Sanea,Abdullah A. Elgazar,Samar S. Tawfik,Abdelrahman Hamdi,(unknown)	1
3	“Triazole-linked thiazolidinedione-Benzothiazole hybrids: Design and biological evaluation as AChE inhibitors” 2025 ·Bioorganic Chemistry ·(unknown),Mohammad M. Al‐Sanea,(unknown),(unknown),Gary S. Thompson,Amira Abood,Mahmoud A. A. Ibrahim,Abdullah A. Elgazar,Abdelrahman Hamdi	1
4	S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study 2024 ·RSC Advances ·Samar S. Tawfik,Abdelrahman Hamdi,(unknown),Abdullah A. Elgazar,(unknown),Adel S. El‐Azab,Ahmed H. Bakheit,Mohamed Hefnawy,Hazem A. Ghabbour,Alaa A.‐M. Abdel‐Aziz	13
5	Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors 2024 ·Drug Design Development and Therapy ·Mohammad M. Al‐Sanea,(unknown),(unknown),(unknown),Abdullah A. Elgazar,Samar S. Tawfik,(unknown),(unknown),(unknown),Abdelrahman Hamdi	7
6	Design, synthesis, and in vitro and in vivo biological evaluation of triazolopyrimidine hybrids as multitarget directed anticancer agents 2024 ·RSC Advances ·(unknown),Samar S. Tawfik,Abdullah A. Elgazar,Khalid B. Selim,Fatma E. Goda	2
7	Unraveling the Nephroprotective Potential of Papaverine against Cisplatin Toxicity through Mitigating Oxidative Stress and Inflammation: Insights from In Silico, In Vitro, and In Vivo Investigations 2024 ·Molecules ·(unknown),Abdullah A. Elgazar,(unknown),(unknown),(unknown),M. A. Bhat,Foad Farrag,Abdelrahman Hamdi,(unknown),Mohammed A. El‐Magd	13
8	Utilization of selected natural products as complementary therapeutic approach for Obstructive Sleep Apnea (OSA) management: a literature review 2024 ·SHILAP Revista de lepidopterología ·Farid A. Badria,Abdullah A. Elgazar	0
9	Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study 2024 ·Bioorganic Chemistry ·(unknown),Abdelrahman Hamdi,(unknown),Abdullah A. Elgazar,Magda N.A. Nasr	27
10	New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study 2023 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Mohammad M. Al‐Sanea,Abdelrahman Hamdi,(unknown),(unknown),(unknown),Abdullah A. Elgazar,Wagdy M. Eldehna,Hidayat Ur Rahman,Della Grace Thomas Parambi,(unknown),Samy Selim,Syed Nasir Abbas Bukhari,(unknown),Samar S. Tawfik	37
11	3-Acetyl-11-keto-β-boswellic Acid-Based Hybrids Alleviate Acetaminophen-Induced Hepatotoxicity in HepG2 by the Regulation of Inflammatory and Oxidative Stress Pathways: An Integrated Approach 2023 ·ACS Omega ·Abdullah A. Elgazar,Ramadan A. El-Domany,Wagdy M. Eldehna,(unknown)	11
12	Theophylline-based hybrids as acetylcholinesterase inhibitors endowed with anti-inflammatory activity: synthesis, bioevaluation,in silicoand preliminary kinetic studies 2023 ·RSC Advances ·Abdullah A. Elgazar,Ramadan A. El-Domany,Wagdy M. Eldehna,Farid A. Badria	16
13	Identification of sulphonamide-tethered N -((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease 2023 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown),Abdullah A. Elgazar,(unknown),(unknown),Zainab M. Elsayed,(unknown),Amira Abood,Mahmoud A. El Hassab,Ahmed M. Soliman,Ramadan A. El-Domany,Farid A. Badria,Claudiu T. Supuran,Wagdy M. Eldehna	17
14	Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights 2023 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Abdelrahman Hamdi,(unknown),(unknown),M. A. Bhat,Noha I. Ziedan,(unknown),(unknown),Mohamed R. Elnagar,(unknown),(unknown),Abdullah A. Elgazar,(unknown),(unknown),(unknown),Mostafa M. Elbadawi	20
15	Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies 2023 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown),Abdelrahman Hamdi,Samar S. Tawfik,Abdullah A. Elgazar,(unknown)	58
16	Natural inspired piperine-based sulfonamides and carboxylic acids as carbonic anhydrase inhibitors: Design, synthesis and biological evaluation 2021 ·European Journal of Medicinal Chemistry ·(unknown),Abdullah A. Elgazar,Alessandro Bonardi,(unknown),Alessio Nocentini,Ramadan A. El-Domany,Hatem A. Abdel‐Aziz,Farid A. Badria,Claudiu T. Supuran,Wagdy M. Eldehna	34
17	Chemical constituents from coconut waste and their in silico evaluation as potential antiviral agents against SARS-CoV-2 2021 ·South African Journal of Botany ·(unknown),Mahmoud A. A. Ibrahim,Fatma M. Abdel Bar,Abdullah A. Elgazar	23
18	Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation 2020 ·European Journal of Medicinal Chemistry ·Mohamed A. Said,Wagdy M. Eldehna,Alessio Nocentini,(unknown),Alessandro Bonardi,Abdullah A. Elgazar,Vladimı́r Kryštof,Dalia H. Soliman,Hatem A. Abdel‐Aziz,Paola Gratteri,Sahar M. Abou‐Seri,Claudiu T. Supuran	58
19	Chrysophanol, Physcion, Hesperidin and Curcumin Modulate the Gene Expression of Pro-Inflammatory Mediators Induced by LPS in HepG2: In Silico and Molecular Studies 2019 ·Antioxidants ·(unknown),Abdullah A. Elgazar,Nabil Mohie Abdel‐Hamid,Mohammed A. El‐Magd,Abdelaziz Yasri,Hala M. El-Hefnawy,Mansour Sobeh	48
20	Insights on the molecular mechanism of anti-inflammatory effect of formula from Islamic traditional medicine: An in-silico study 2018 ·Journal of Traditional and Complementary Medicine ·Abdullah A. Elgazar,(unknown),(unknown)	19

About Abdullah A. Elgazar

Abdullah A. Elgazar is a scholar working on Pharmacology, Organic Chemistry and Computational Theory and Mathematics, having authored 30 papers that have together received 583 indexed citations. Recurring topics across this work include Synthesis and biological activity (7 papers), Computational Drug Discovery Methods (7 papers) and Click Chemistry and Applications (6 papers). The work is most often cited by research in Organic Chemistry (327 citations), Pharmacology (69 citations) and Computational Theory and Mathematics (76 citations). Abdullah A. Elgazar has collaborated with scholars based in Egypt, Saudi Arabia and United Kingdom. Frequent co-authors include Abdelrahman Hamdi, Farid A. Badria, Wagdy M. Eldehna, Mohammed A. El‐Magd, Samar S. Tawfik, Hala M. El-Hefnawy, Nabil Mohie Abdel‐Hamid, Ramadan A. El-Domany, Claudiu T. Supuran and Alessandro Bonardi. Their work appears in journals such as SHILAP Revista de lepidopterología, Chemistry - A European Journal and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact